Nick studied biomedical sciences at the University of Manchester, including one year at the Cancer Research UK Manchester Institute working on DNA damage and repair. He then ventured down south, completing a PhD at the Cancer Research UK London Research Institute on the signals that help cells move. He joined the News and Multimedia team in 2013, helping to manage the charity’s blog and news feed.
The 2019 ASCO conference news highlights: a year of progress with targeted drugs trialled in prostate, pancreatic, breast and lung cancers.
In the news this week: cervical cancer prevention, sugary drinks and should we rename certain ‘low risk’ cancers?
In the news this week: a new experimental cervical cancer test and England’s top doctor calls for a tax on unhealthy foods.
The top stories from the 2018 ASCO annual meeting: overexcited coverage of cancer blood tests and how a gene test can tailor breast cancer treatment.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Step inside a virtual world where our Grand Challenge scientists are hoping to redefine the way we look at cancer.
Combining new ways to measure molecules could lead to the most accurate picture of tumours ever created. We explore the science behind the approach.
A big week for CRISPR genome editing, GPs need support on cancer-preventing drugs and can this ‘treatment’ really make pancreatic cancer manageable?
The ‘signatures’ that tobacco leaves in DNA, ‘devastating’ new childhood obesity figures, and can scientists make their own stars?